EMA Authorised: Cholestagel (colesevelam (as hydrochloride)) — CHEPLAPHARM Arzneimittel GmbH

View source ↗

Summary

The EMA authorised Cholestagel (colesevelam as hydrochloride) for hypercholesterolemia, with CHEPLAPHARM Arzneimittel GmbH as the marketing authorization holder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Cholestagel (colesevelam (as hydrochloride))

Snippet

Status: Authorised. Therapeutic area: Hypercholesterolemia. MAH: CHEPLAPHARM Arzneimittel GmbH. Decision date: 03/06/2025